Point72 (DIFC)’s Outset Medical OM Stock Holding History

Point72 (DIFC)’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,687	Closed	-$97.4K	–	1709
2024 Q2	$97.4K	Buy	1,687 +456	+37%	+$22.3K	﹤0.01%	977
2024 Q1	$41K	Buy	+1,231	New	+$62.3K	﹤0.01%	1227

Other funds holding OM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

MIC

Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Point72 (DIFC)'s OM Position: Q3 2024 in Review

Point72 (DIFC) sold out of Outset Medical (OM) in Q3 2024, closing a stake of 1,687 shares — an estimated $97.4K sold.

Point72 (DIFC) first reported a position in OM in Q1 2024 and held it in 2 quarters. The position peaked at $97.4K in Q2 2024. 78 funds tracked by Wall St. Rank hold OM as of Q3 2024.

Point72 (DIFC) reported no remaining Outset Medical position as of Q3 2024 after selling out during the quarter.
Point72 (DIFC) sold 1,687 Outset Medical shares in Q3 2024, an estimated $97.4K.
Point72 (DIFC) first reported a position in Outset Medical in Q1 2024 and held it in 2 quarters.
Point72 (DIFC)'s Outset Medical position peaked at $97.4K in Q2 2024.
78 funds tracked by Wall St. Rank held Outset Medical as of Q3 2024.

Based on Point72 (DIFC)'s 13F filing for Q3 2024, filed 14 Nov 2024.